Literature DB >> 17661915

Analysis of the HFE gene (C282Y, H63D and S65C) mutations in a general Chinese Han population.

A Lin1, W H Yan, H H Xu, M Zhu, M Y Zhou.   

Abstract

Hereditary hemochromatosis (HH) is one of the most common autosomal recessive genetic disorders of iron metabolism in white populations, which leads to inappropriately high iron absorption. C282Y, H63D, and S65C are three major missense mutations of the hemochromatosis gene (HFE). In the present study, C282Y, H63D, and S65C mutations in 395 normal Chinese Han populations from Zhejiang province were investigated. No C282Y, S65C mutations, and H63D homozygote was observed, while the genotype frequency of H63D heterozygote was 4.6% and the allelic frequency 2.3% in this population. This was the first report to analyze the prevalence of C282Y, H63D, and S65C mutations in the HFE gene in a Chinese Han population. Low incidence of the HFE gene mutations could be a reason for the rarity of HH in the Chinese Han population studied.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17661915     DOI: 10.1111/j.1399-0039.2007.00877.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  An association study of HFE gene mutation with idiopathic male infertility in the Chinese Han population.

Authors:  Xiao-Ying Yu; Bin-Bin Wang; Zhong-Cheng Xin; Tao Liu; Ke Ma; Jian Jiang; Xiang Fang; Li-Hua Yu; Yi-Feng Peng; Xu Ma
Journal:  Asian J Androl       Date:  2012-04-16       Impact factor: 3.285

2.  Two middle-age-onset hemochromatosis patients with heterozygous mutations in the hemojuvelin gene in a Chinese family.

Authors:  Shufeng Li; Jun Xue; Baojun Chen; Qiwei Wang; Minke Shi; Xiaojing Xie; Liang Zhang
Journal:  Int J Hematol       Date:  2014-03-02       Impact factor: 2.490

3.  Effect of the Hemochromatosis Mutations on Iron Overload among the Indian β Thalassemia Carriers.

Authors:  Anita H Nadkarni; Aradhana A Singh; Stacy Colaco; Priya Hariharan; Roshan B Colah; Kanjaksha Ghosh
Journal:  J Clin Lab Anal       Date:  2016-08-26       Impact factor: 2.352

4.  The effect of the hemochromatosis (HFE) genotype on lead load and iron metabolism among lead smelter workers.

Authors:  Guangqin Fan; Guihua Du; Huijun Li; Fen Lin; Ziyong Sun; Wei Yang; Chang Feng; Gaochun Zhu; Yanshu Li; Ying Chen; Huan Jiao; Fankun Zhou
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

5.  Hemochromatosis as Junctional Tachycardia, a Rare Presentation.

Authors:  Ali Ghani; Irfan Ahsan; Charles Gottleib
Journal:  Clin Pract       Date:  2017-08-03

6.  Interactive Effects between Chronic Lead Exposure and the Homeostatic Iron Regulator Transport HFE Polymorphism on the Human Red Blood Cell Mean Corpuscular Volume (MCV).

Authors:  Chien-Juan Chen; Ting-Yi Lin; Chao-Ling Wang; Chi-Kung Ho; Hung-Yi Chuang; Hsin-Su Yu
Journal:  Int J Environ Res Public Health       Date:  2019-01-27       Impact factor: 3.390

7.  HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case.

Authors:  Wei Zhang; Xiaoming Wang; Weijia Duan; Anjian Xu; Xinyan Zhao; Jian Huang; Hong You; Pierre Brissot; Xiaojuan Ou; Jidong Jia
Journal:  Front Genet       Date:  2020-02-21       Impact factor: 4.599

8.  Non-Heme Iron Absorption and Utilization from Typical Whole Chinese Diets in Young Chinese Urban Men Measured by a Double-Labeled Stable Isotope Technique.

Authors:  Lichen Yang; Yuhui Zhang; Jun Wang; Zhengwu Huang; Lingyan Gou; Zhilin Wang; Tongxiang Ren; Jianhua Piao; Xiaoguang Yang
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

9.  Carriers of the Complex Allele HFE c.[187C>G;340+4T>C] Have Increased Risk of Iron Overload in São Miguel Island Population (Azores, Portugal).

Authors:  Claudia C Branco; Cidália T Gomes; Laura De Fez; Sara Bulhões; Maria José Brilhante; Tânia Pereirinha; Rita Cabral; Ana Catarina Rego; Cristina Fraga; António G Miguel; Gracinda Brasil; Paula Macedo; Luisa Mota-Vieira
Journal:  PLoS One       Date:  2015-10-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.